Skip to main content

Patient Education Resources

146 Patient Education Resources

Erythropoieis-stimulating Agent (ESA) Therapy and Chronic Kidney Disease (CKD)

| .pdf | PRINT CODE WQ85-1493

Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.

Erythropoieis-stimulating Agents (ESAs) for Chronic Kidney Disease (CKD): With Active Cancer or a History of Cancer or Stroke

| .pdf | PRINT CODE WQ85-2217

Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet looks at this the risks and benefits of ESAs if you have/have had cancer or a stroke.

Extravasation Care for Cancer Patients

| .pdf | PRINT CODE NSHCCP-4059

During your systemic therapy treatment, a rare complication may have occurred called extravasation. This is when a drug leaks out of the vein and under the skin. This pamphlet outlines what to do if this happens, including skin care, treatment, and other things to know.

Fer injectable et insuffisance rénale chronique (IRC)

| .pdf | PRINT CODE FF85-2161

Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver. This pamphlet is also available in English.

©2024 Nova Scotia Health Authority. All rights reserved.